or overall rate of febrile neutropenia was 9% of patients treated with pegfilgrastim and 18% of patients treated with filgrastim (difference 9%, 95% CI of -16.8%, -1.1%).
betegeknél 9%, a filgrasztimmal kezelt betegeknél 18% volt (különbség 9%, 95% CI – 16, 8% - 1, 1%). ba m